The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Complication Rate of Right Ventricular Endomyocardial Biopsy via the Femoral Approach: A Retrospective and Prospective Study Analyzing 3048 Diagnostic Procedures Over an 11-Year Period
Open accessAbstract
Background— An unequivocal diagnosis of myocarditis and cardiac virus persistence is based on histological, immunohistological, and molecular biological analyses of endomyocardial biopsies (EMBs). Biopsy-based diagnosis of myocarditis has become increasingly important because recent studies have demonstrated the beneficial effects of biopsy-based causal treatment strategies (immunosuppressive or antiviral). Because the risks of major complications caused by EMB procedures have not yet been well defined, we evaluated the incidence of major and minor complications of right ventricular EMB procedures in this retrospective and prospective single-center study. Methods and Results— With the use of a modified Cordis bioptome, 1919 patients underwent 2505 EMB procedures retrospectively over a 9-year period (January 1995 to December 2003), and 496 patients underwent 543 EMB procedures prospectively between January 2004 and December 2005. A total of 2415 patients had 3048 EMB procedures via the right femoral vein approach under biplane fluoroscopic control to evaluate unexplained left ventricular dysfunction (retrospective left ventricular ejection fraction, 49.8±18.8%; prospective, 48.8±19.7%) after exclusion of secondary causes. During each EMB procedure, an average of 8.2±0.8 EMBs were obtained retrospectively and 10.1±0.6 specimens prospectively for a total of 26 025 specimens. No patient died or required emergency cardiac surgery. Other major complications like cardiac tamponade requiring pericardiocentesis or complete atrioventricular block requiring permanent pacing were very rare: 0.12% in the retrospective study and 0% in the prospective study. Minor complications such as pericardial effusion, conduction abnormalities, or arrhythmias occurred in 0.20% of the EMB procedures in the retrospective study and 5.5% in the prospective study. Conclusions— The EMB procedure via the femoral vein approach under fluoroscopic guidance has a very low complication rate when performed by experienced operators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Maron, B. J., Towbin, J. A., Thiene, G., Antzelevitch, C., Corrado, D., Arnett, D., Moss, A. J., Seidman, C. E., & Young, J. B. (2006) · Circulation · doi:10.1161/circulationaha.106.174287 · Cited by 3,436
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Mahrholdt, H., Goedecke, C., Wagner, A., Meinhardt, G., Athanasiadis, A., Vogelsberg, H., Fritz, P., Klingel, K., Kandolf, R., & Sechtem, U. (2004) · Circulation · doi:10.1161/01.cir.0000118493.13323.81 · Cited by 1,030
Kühl, U., Pauschinger, M., Noutsias, M., Seeberg, B., Bock, T., Lassner, D., Poller, W., Kandolf, R., & Schultheiss, H.-P. (2005) · Circulation · doi:10.1161/01.cir.0000155616.07901.35 · Cited by 712
Self-citationTilson, M. D. (2005) · Circulation · doi:10.1161/circulationaha.105.553370 · Cited by 654
Myocarditis: Current Trends in Diagnosis and Treatment
Magnani, J. W., & Dec, G. W. (2006) · Circulation · doi:10.1161/circulationaha.105.584532 · Cited by 610
Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction
Kühl, U., Pauschinger, M., Seeberg, B., Lassner, D., Noutsias, M., Poller, W., & Schultheiss, H.-P. (2005) · Circulation · doi:10.1161/circulationaha.105.548156 · Cited by 603
Self-citationControlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy
McNamara, D. M., Holubkov, R., Starling, R. C., Dec, G. W., Loh, E., Torre-Amione, G., Gass, A., Janosko, K., Tokarczyk, T., Kessler, P., et al. (2001) · Circulation · doi:10.1161/01.cir.103.18.2254 · Cited by 560
Kühl, U., Pauschinger, M., Schwimmbeck, P. L., Seeberg, B., Lober, C., Noutsias, M., Poller, W., & Schultheiss, H.-P. (2003) · Circulation · doi:10.1161/01.cir.0000072766.67150.51 · Cited by 503
Self-citation
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Caforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479
2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease
Pelliccia, A., Sharma, S., Gati, S., Bäck, M., Börjesson, M., Caselli, S., Collet, J.-P., Corrado, D., Drezner, J. A., Halle, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa605 · Cited by 1,958
Sagar, S., Liu, P. P., & Cooper, L. T. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60648-x · Cited by 743
Schultheiss, H.-P., Fairweather, D., Caforio, A. L. P., Escher, F., Hershberger, R. E., Lipshultz, S. E., Liu, P. P., Matsumori, A., Mazzanti, A., McMurray, J., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0084-1 · Cited by 720
Viral myocarditis—diagnosis, treatment options, and current controversies
Pollack, A., Kontorovich, A. R., Fuster, V., & Dec, G. W. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.108 · Cited by 657
Leone, O., Veinot, J. P., Angelini, A., Baandrup, U. T., Basso, C., Berry, G., Bruneval, P., Burke, M., Butany, J., Calabrese, F., et al. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2011.10.001 · Cited by 535
Yilmaz, A., Kindermann, I., Kindermann, M., Mahfoud, F., Ukena, C., Athanasiadis, A., Hill, S., Mahrholdt, H., Voehringer, M., Schieber, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.924167 · Cited by 431
Blauwet, L. A., & Cooper, L. T. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2009.11.006 · Cited by 374
Sado, D. M., Flett, A. S., Banypersad, S. M., White, S. K., Maestrini, V., Quarta, G., Lachmann, R. H., Murphy, E., Mehta, A., Hughes, D. A., et al. (2012) · Heart · doi:10.1136/heartjnl-2012-302346 · Cited by 357
Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis
Zhang, L., Awadalla, M., Mahmood, S. S., Nohria, A., Hassan, M. Z. O., Thuny, F., Zlotoff, D. A., Murphy, S. P., Stone, J. R., Golden, D. L. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa051 · Cited by 355
Schultheiss, H.-P., Kuhl, U., & Cooper, L. T. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr165 · Cited by 301
Self-citationInflammatory Cardiomyopathic Syndromes
Trachtenberg, B. H., & Hare, J. M. (2017) · Circulation Research · doi:10.1161/circresaha.117.310221 · Cited by 289
Management of Myocarditis-Related Cardiomyopathy in Adults
Tschöpe, C., Cooper, L. T., Torre-Amione, G., & Van Linthout, S. (2019) · Circulation Research · doi:10.1161/circresaha.118.313578 · Cited by 279
Caforio, A. L. P., Adler, Y., Agostini, C., Allanore, Y., Anastasakis, A., Arad, M., Böhm, M., Charron, P., Elliott, P. M., Eriksson, U., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx321 · Cited by 263
Seferović, P. M., Tsutsui, H., McNamara, D. M., Ristić, A. D., Basso, C., Bozkurt, B., Cooper, L. T., Filippatos, G., Ide, T., Inomata, T., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2190 · Cited by 219
Idiopathic giant cell myocarditis and cardiac sarcoidosis
Blauwet, L. A., & Cooper, L. T. (2013) · Heart Failure Reviews · doi:10.1007/s10741-012-9358-3 · Cited by 119
Ammirati, E., Buono, A., Moroni, F., Gigli, L., Power, J. R., Ciabatti, M., Garascia, A., Adler, E. D., & Pieroni, M. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01680-x · Cited by 98
Brala, D., Thevathasan, T., Grahl, S., Barrow, S., Violano, M., Bergs, H., Golpour, A., Suwalski, P., Poller, W., Skurk, C., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.027619 · Cited by 54
Self-citationIsogai, T., Yasunaga, H., Matsui, H., Ueda, T., Tanaka, H., Horiguchi, H., & Fushimi, K. (2015) · Clinical Cardiology · doi:10.1002/clc.22368 · Cited by 35
Genomic and Proteomic Analysis of Myocarditis and Dilated Cardiomyopathy
Cooper, L. T., Onuma, O. K., Sagar, S., Oberg, A. L., Mahoney, D. W., Asmann, Y. W., & Liu, P. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.08.012 · Cited by 30
“Furthermore, the risks of biopsy include up to a 1 in 1000 risk of death and 1 in 250 risk of perforation.(57) The risks and variable sensitivity of EMB for myocardial diseases have generated an interest in noninvasive diagnostic methods, including serum proteomics.”
Background
Metadata
- Authors
- Holzmann, M., Nicko, A., Kühl, U., Noutsias, M., Poller, W., Hoffmann, W., Morguet, A., Witzenbichler, B., Tschöpe, C., Schultheiss, H.-P., & Pauschinger, M.
- Venue
- Circulation
- Published
- 2008-10-21
- Volume
- 118
- Issue
- 17
- Pages
- 1722-1728
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2018492572
- Cited by
- 258
- References
- 28
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.